Clinical Trial

Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock

Name: Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock — clinical trial record (NCT07383103)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy and safety of the combination therapy of hydrocortisone and fludrocortisone among adult patients with septic shock.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-01.

Status change: Not Yet Recruiting → Recruiting 2026-03-03

Trial Details

NCT Number	NCT07383103
Lead Sponsor	Northern Jiangsu People's Hospital
Conditions	Septic Shock
Enrollment	336 participants
Start Date	2026-03-02
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-04